Jonathan Allan sold $17K of Stoke Therapeutics stock
By AlphaYouPublished Form 4
Allan Jonathan
Reporting filer
Jonathan Allan reported selling 627 shares of Stoke Therapeutics, Inc. for about $17K ($26.33 a share on average). Form 4 filed Oct 2, 2026 lists 1 entry.
See the price move since this trade →
- Disclosed
- Oct 2, 2026
Reported details
1 entry| Security | Owner | Date | Code | Action | Quantity | Price | Following holdings | Reporting delay | Filed terms and references |
|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Allan Jonathan | 2026-10-02 | S | Sale | 627 | 26.33 | 20,598 | 0 days | Filed terms
|
Common Stock
- Owner
- Allan Jonathan
- Date
- 2026-10-02
- Code
- S
- Action
- Sale
- Quantity
- 627
- Price
- 26.33
- Following holdings
- 20,598
- Reporting delay
- 0 days
- Filed terms and references
Filed terms
- security Title: Common Stock
- transaction Date: 2026-10-02
- transaction Form Type: 4
- transaction Code: S
- equity Swap Involved: 0
- id: F1
- transaction Shares: 627
- transaction Price Per Share: 26.33
- transaction Acquired Disposed Code: D
- shares Owned Following Transaction: 20598
- direct Or Indirect Ownership: D
- nature Of Ownership:
Purchases, sales, grants and option exercises are different transactions. The reported code identifies the action; it does not establish a motive.
Filing context
- Quantities and prices are shown in the units filed. No trade value is inferred from their product.
- Allan Jonathan: GENERAL COUNSEL & CORP SEC.
- The filing reports a Rule 10b5-1 trading plan.
- F1: This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 10, 2025.
Original sources
Prepared automatically from public filing data. Report a correction.